Literature DB >> 27446289

Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy.

Pang-Hu Zhou1, Lei Shi2, Wei Hu3, Xiao-Bin Zhang3, Wei Wang3, Li-Jun Zhang3.   

Abstract

The aim of the present study was to investigate the pathophysiological functions of adrenomedullin (ADM), atrial and brain natriuretic peptides (ANP and BNP) in patients with adrenal medullary hyperplasia (AMH). Plasma ADM, ANP and BNP concentrations were measured in 20 patients with AMH, 35 patients with essential hypertension (EH), and 40 healthy control subjects. Following effective antihypertensive therapy, the values in AMH and EH patients were measured again and laparoscopic adrenalectomy was performed for AMH patients. At 2 weeks after surgery, the three peptides were measured again. The AMH patients had higher plasma concentrations of ADM, ANP and BNP compared with the EH and control subjects. There were significant differences in the values of ADM, ANP and BNP between adrenal vein and inferior vena cava and between AMH and contralateral adrenal vein. Plasma ADM concentration was correlated with serum epinephrine and norepinephrine and urine vanillylmandelic acid, in addition to systolic and diastolic blood pressure, left ventricular ejection fraction, left ventricular mass index and ANP and BNP values in the AMH group. Following antihypertensive treatment, ADM, ANP and BNP were significantly decreased in EH patients, but remained unchanged in AMH subjects. However, these concentrations significantly decreased following surgery. Therefore, the present results suggest that ADM, ANP and BNP may be involved in regulating adrenal medulla functions.

Entities:  

Keywords:  adrenal medullary hyperplasia; adrenomedullin; atrial natriuretic peptide; brain natriuretic peptide

Year:  2016        PMID: 27446289      PMCID: PMC4950839          DOI: 10.3892/etm.2016.3418

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  Plasma adrenomedullin level and development of hypertension.

Authors:  J Kato; K Kitamura; T Eto
Journal:  J Hum Hypertens       Date:  2006-04-20       Impact factor: 3.012

2.  Plasma adrenomedullin concentrations in patients with adrenal pheochromocytoma.

Authors:  C Letizia; G De Toma; C Caliumi; S Cerci; R Massa; R D Loria; P Alo; E M Marinoni; D Diacinti; E D'Erasmo
Journal:  Horm Metab Res       Date:  2001-05       Impact factor: 2.936

Review 3.  Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Claudio Passino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

4.  One-step direct assay for mature-type adrenomedullin with monoclonal antibodies.

Authors:  H Ohta; T Tsuji; S Asai; K Sasakura; H Teraoka; K Kitamura; K Kangawa
Journal:  Clin Chem       Date:  1999-02       Impact factor: 8.327

5.  Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. 1993.

Authors:  Kazuo Kitamura; Kenji Kangawa; Mari Kawamoto; Yoshinari Ichiki; Shigeru Nakamura; Hisayuki Matsuo; Tanenao Eto
Journal:  Biochem Biophys Res Commun       Date:  2012-08-31       Impact factor: 3.575

6.  A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma.

Authors:  H Ohta; T Tsuji; S Asai; S Tanizaki; K Sasakura; H Teraoka; K Kitamura; K Kangawa
Journal:  Clin Chim Acta       Date:  1999-09       Impact factor: 3.786

Review 7.  Endothelial actions of atrial and B-type natriuretic peptides.

Authors:  Michaela Kuhn
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

8.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.

Authors:  Hayet Soualmia; Ilhem Ayadi; Souheil Omar; Moncef Feki; Habiba Drissa; Abderraouf Mebazaa; Naziha Kaabachi
Journal:  Clin Lab       Date:  2009       Impact factor: 1.138

10.  Natriuretic Peptide system and cardiovascular disease.

Authors:  Cacciapuoti Federico
Journal:  Heart Views       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.